Valion Bio, Inc. insider trading

VBIONASDAQ

$2.48-0.11 (-4.25%)as of Oct 5, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-96.7%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

JEJennifer ErnstChief Executive Officer0.0059%of company
CRChristina Rizopoulos ValauriDirector0.0034%of company
MKMichael K. HandleyChief Executive Officer0.002%of company
SBSheryle BoltonDirector0.0018%of company
LGLisa G. WolfCOO & CFO0.0001%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
VBIO	Sheryle BoltonDirector	Open market purchase$10.4K	Not reported	$1.04	$10.4K	Apr 15, 2026	Apr 20, 2026
VBIO	Christina Rizopoulos ValauriDirector	Open market purchase$18.1K	Not reported	$0.95	$18.1K	Apr 1, 2026	Apr 2, 2026

End of history · 2 transactions